Form 4: UNH Chief Accounting Officer Receives Equity Awards

UnitedHealth Group's Chief Accounting Officer, Thomas E. Roos, was granted restricted stock units and non-qualified stock options, alongside a disposition of shares for tax purposes.

Summary

• Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group Inc. (UNH), reported transactions on February 23, 2026.
• Roos disposed of 151.777 shares of Common Stock at a price of $282.34 per share, likely for tax withholding related to equity vesting.
• He acquired 2,436 shares of Common Stock in the form of restricted stock units (RSUs) at a price of $0.
• These RSUs will vest at a rate of 25% annually on February 23 from 2027 through 2030.
• Roos also acquired 9,768 non-qualified stock options with an exercise price of $282.34.
• These stock options will vest at a rate of 25% annually on February 23 from 2027 through 2030 and expire on February 23, 2036.
• Following these transactions, Roos beneficially owns 31,283.641 shares of Common Stock directly and 9,768 derivative securities (options) directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine and moderately positive event, as it reinforces the alignment of the Chief Accounting Officer's incentives with the company's long-term performance and shareholder value.

Positives

• The grant of restricted stock units and non-qualified stock options aligns the Chief Accounting Officer's interests with long-term shareholder value.
• Equity compensation is a standard practice for retaining and incentivizing key executives.

Negatives

• The disposition of 151.777 shares, while likely for tax purposes, represents a slight reduction in direct common stock ownership.

Future Outlook

The filing details future vesting schedules for the granted restricted stock units and non-qualified stock options, indicating that 25% will vest annually on February 23 from 2027 through 2030. The non-qualified stock options have an expiration date of February 23, 2036.

Industry Context

StockSavvy.ai notes that equity grants, such as restricted stock units and stock options with multi-year vesting schedules, are a common and established practice in executive compensation across the healthcare industry. This approach is designed to align the long-term interests of key management personnel with those of shareholders, fostering sustained performance and retention.

Comparison to Industry Standards

• The structure of the equity grants, including multi-year vesting schedules, is consistent with standard executive compensation practices observed in large-cap healthcare companies.
• While specific comparable companies or projects are not detailed in this filing, the use of both restricted stock units and stock options is a common dual approach to incentivize executives, balancing retention with performance-based upside potential.

Related Party Transactions

• The acquisition of restricted stock units and non-qualified stock options by Thomas E. Roos, an officer of UnitedHealth Group, constitutes a transaction with a related party (the issuer) as part of his compensation package.

Stakeholder Impact

• Shareholders: The equity grants are intended to align the Chief Accounting Officer's long-term interests with shareholder value, potentially leading to improved company performance.
• Employees (specifically the officer): The grants serve as a significant component of executive compensation, incentivizing retention and performance.

Next Steps

• The restricted stock units and non-qualified stock options will vest annually at a rate of 25% on February 23 from 2027 through 2030.

Key Dates

Recommendation

A Form 4 filing primarily discloses routine insider transactions related to equity compensation and does not typically contain new material information that would fundamentally alter a seasoned investor's investment thesis or recommendation for the stock. These are standard compensation events.

Keywords

UNH, UnitedHealth Group, Form 4, Insider Transaction, Equity Compensation, Restricted Stock Units, Stock Options, Thomas E. Roos